Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion type Assertion NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_head.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion description "[Overall, heterozygous TPMT genotypes did not predict adverse drug reactions but were significantly associated with a subgroup of patients experiencing nausea and vomiting as the predominant adverse reaction to AZA therapy (OR 5.5, 95% CI 1.4-21.3, P = 0.0206).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_provenance.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion evidence source_evidence_literature NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_provenance.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion SIO_000772 15167706 NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_provenance.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion wasDerivedFrom befree-2016 NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_provenance.
- NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_assertion wasGeneratedBy ECO_0000203 NP446004.RAhlLa5KVXSXYBfFFqtCOX50S2fXhAUdAVqPZ2E5VoX2s130_provenance.